David Gisselsson

Academic adventurer interested in cancer, evolution, strategy and leadership. Contemplating how to uphold democracy when medicine and politics collide.

[David Gisselsson @DGisselsson]

A new DDLS position in data driven precision medicine is now announced from @Lundsuni ! Application opens Saturday July 15 - looking forward to many excellent candidates, just like last time.
https://t.co/8jqIIe6i1s

[David Gisselsson @DGisselsson]

A new DDLS position in data driven infection biology/epidemiology is now announced from @Lundsuni ! Application opens Saturday July 15 - looking forward to many excellent candidates, just like last time.

https://t.co/az1f2mzNGr

[David Gisselsson @DGisselsson]

The story is also covered in this podcast!
https://t.co/GeWguNP4zE

[David Gisselsson @DGisselsson]

Can military strategy and intelligence methodology inspire new ways to treat cancer? Have a look at our recent paper in @trendscancer
https://t.co/3ocD3VE9Dp

[David Gisselsson @DGisselsson]

@trendscancer Finally, we introduce the the F3EAD anti-terror intel cycle to the world of cancer, stressing the importance of capitalising on molecular data from cancer cells having survived treatment to plan for our next move.

[David Gisselsson @DGisselsson]

@trendscancer We then go deeper into the Cold War Soviet concept of "reflexive control" as a starting point to how we can lure/shape cancer cell populations to become more, not less vulnerable to treatment over time.

[David Gisselsson @DGisselsson]

@trendscancer We then point to three critical vulnerabilities of cancer cells, where the host (patient) has an advantage but where cancer is at a disadvantage: (1) Cell-cell collaboration (2) Host-resource dependence, and (3) Lack of long-term planning.

[David Gisselsson @DGisselsson]

@trendscancer We start by looking at cancer drug resistance to highlight the "antagonistic" features of cancer, i.e. that our therapeutic actions are bound to create a defensive reaction towards resistance in many cancers. We compare this to Clausewitz's concept of Zweikampf

[David Gisselsson @DGisselsson]

@trendscancer This was a collaboration between the Cancer Cell Evolution Unit at @medfak_LU and @tonyingesson, an expert in intelligence studies @lunduniversity

[Mick Ryan, AM @WarintheFuture]

In a 1973 lecture Sir Michael Howard discussed surprise, noting “this is an aspect...which needs to be studied above all others in the Armed Forces: the capacity to adapt oneself to the utterly unpredictable, the entirely unknown. Today, another surprise. 1/25🧵

[Barncancerfonden @barncancerfond]

Positivt besked från @socialdep: ytterligare 10 miljoner kronor till GMS Barncancer för att säkerställa att alla barn som insjuknar i cancer även fortsättningsvis ska kunna erbjudas helgenomsekvensering. https://t.co/mBuDzJqlor

[Genomic Medicine Sweden @genomicmedswe]

Positivt besked från @socialdep om ytterligare 10 milj kr till GMS barncancer så att alla barn som insjuknar i cancer fortsatt kan erbjudas helgenomsekvensering. "Vi är mycket glada och tacksamma över en förlängd finansiering!", säger @DGisselsson.
https://t.co/bmtXYIRUoT

[David Gisselsson @DGisselsson]

https://t.co/PIiq2kabpk

[David Gisselsson @DGisselsson]

@socialdep @AckoAnkarberg Vi är så otroligt tacksamma -- genom detta kan vi fortsätta att erbjuda våra patienter i hela Sverige världsledande cancerdiagnostik! En sådan glädje.

[Socialdepartementet @socialdep]

Genom att erbjuda alla barn med cancer helgenomsekvensering har vi tagit ett mycket viktigt steg inom barncancervården, ett steg som möjliggör en mer precis diagnos och effektivare behandling, säger @AckoAnkarberg Johansson. #vårdpol
https://t.co/2BPzKx5rOf

[Barncancerfonden @barncancerfond]

Många länder har infört helgenomsekvensering för vissa barncancerpatienter. Tack vare finansiering från Barncancerfonden och @socialdep kan Sverige som enda land erbjuda alla barn med cancer denna diagnostik. Läkaren @DGisselsson berättar om nästa steg.
https://t.co/mLKQ10ONh3

[David Gisselsson @DGisselsson]

@EszterLakatos42 Congratulations to you Eszter but not least to us in the Swedish math onco community 🇸🇪 What a booster 🎉 We really look forward to working witb you and seeing a lot of you also @lunduniversity

[Eszter Lakatos @EszterLakatos42]

I have some exciting news! I'm embarking on a new adventure: Assistant Professor in applied maths at Chalmers University of Technology in the (momentarily) sunny city of Gothenburg!
Any recommendations for office plants? :) (and please send other #newPI advice too)

[Alex Graudenzi @AGraudenzi]

.@MarcoxaShowlow @bud_mishra @AndreaSottoriva and I are glad to announce the 2023 Como School on #Cancer #Evolution!

https://t.co/8JnYMBWksU

Amazing list of speakers!
C Cantor @landau_lab @IulianaLaza R Murphy @Pelicci1 @dposada_ @dany9685 @maria_rescigno @ewa_szczurek + more!

[Genomic Medicine Sweden @genomicmedswe]

GMS #barncancer i dagens DN tema - Svenska välfärden.
"Det vi kan se så här långt är att resultaten från den utökade satsningen på barncancer kommer ge viktig lärdom även för det framtida arbetet med bred genetisk diagnostik vid vuxencancer."
Stöd av @barncancerfond & @socialdep